Tg Therapeutics (TGTX) Work In Process (2023 - 2025)

Tg Therapeutics' Work In Process history runs 3 years deep, the most recent figure standing at $121.8 million for Q3 2025.

• On a quarterly basis, Work In Process rose 62.47% year-over-year to $121.8 million in Q3 2025; TTM through Sep 2025 was $121.8 million, a 62.47% increase from a year earlier, with the FY2024 full-year figure at $68.4 million, up 118.84% from the prior year.
• Work In Process eased to $121.8 million in Q3 2025 per TGTX's latest filing, from $129.2 million in the prior quarter.
• Across five years, Work In Process topped out at $142.9 million in Q1 2025 and bottomed at $27.1 million in Q1 2023.
• The 3-year median for Work In Process is $74.1 million (2024), against an average of $73.5 million.
• Across the five-year window, Work In Process soared 172.99% in 2024 and jumped 62.47% in 2025, its largest moves.
• Year by year, Work In Process stood at $31.2 million in 2023, then soared by 118.84% to $68.4 million in 2024, then jumped by 78.16% to $121.8 million in 2025.
• Per Business Quant, the three latest TGTX Work In Process figures stand at $121.8 million (Q3 2025), $129.2 million (Q2 2025), and $142.9 million (Q1 2025).